Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, October 1998, p. 2745-2746, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Enhancement of Antimicrobial Activity of
Neuropeptide Y by N-Terminal Truncation
Mayumi
Shimizu,
Yasushi
Shigeri,
Yoshiro
Tatsu,
Susumu
Yoshikawa, and
Noboru
Yumoto*
Osaka National Research Institute, AIST,
Ikeda, Osaka 563-8577, Japan
Received 13 April 1998/Returned for modification 13 May
1998/Accepted 10 July 1998
 |
ABSTRACT |
The activity of neuropeptide Y (NPY) against Candida
albicans, which was revealed to be fungicidal, was enhanced
significantly by the truncation of amino acid residues at the N
terminus. The most active peptides (MICs, approximately 1 µM) were
about 10-fold more potent than the intact NPY (MIC, approximately 10 µM). The enhancement was weakened by the replacement of the N
terminus by negatively charged residues and/or acylation of the
-amino group. These results suggest that only the
-helical region
of NPY is necessary for the antimicrobial activity and that the net charge of the peptide is important for the activity.
 |
TEXT |
Neuropeptide Y (NPY) is an amidated
peptide of 36 amino acids and is known to regulate physiological
functions, such as food intake, learning behavior, vasoconstriction,
and neurotransmitter release (10). In addition to these
functions, NPY has been recently reported to have activity against
Cryptococcus neoformans, Candida albicans, and
Arthroderma simii (8). NPY is suggested to belong to a group of antimicrobial peptides such as dermaseptins, cecropins, or magainins (8), which are helical and devoid of cysteine. The antimicrobial mechanism of this group is considered to involve initial electrostatic interactions between the positive charges of the
peptides and the negative charges of the cell membrane, following
penetration of the peptides into the membrane, and then formation of
lipid bilayer-spanning pores which results in osmolysis (1).
It is generally thought that a length of approximately 20 residues is
necessary to provide an
-helix capable of spanning the bilayer. The
three-dimensional structure of NPY is considered to consist of an
amphipathic
-helix (residues 14 to 32) that corresponds to this
length, a polyproline helix (residues 1 to 8), a
-turn (residues 9 to 13), and a flexible tail (residues 33 to 36) (3, 6). In
this study, to determine whether the
-helical region is responsible
for the antimicrobial activity of NPY, we have investigated the effects
of truncation at the N terminus on the activity and found that removal
of 10 to 12 amino acids from the N terminus caused a significant
increase in the activity. Then, to clarify the involvement of
electrostatic interactions in the antimicrobial mechanism of NPY, we
have synthesized peptides in which net charges were changed by
replacement of the N-terminal residues and/or acylation of the
-amino groups.
Porcine NPY
(YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2)
and its analogs were synthesized on an automated solid-phase peptide synthesizer (PSSM-8; Shimadzu, Kyoto, Japan), using Tenta Gel TG-RAM resin and
Fmoc (9-fluorenylmethoxycarbonyl) chemistry as previously de-scribed (5). Acetylation and succinylation of the
-amino
groups of the NPY analogs were performed before cleavage from the resin as previously described (5). C. albicans ATCC
885-653, which was originally from the Institute of Virology and
Microbiology of the Ukraine Academy of Sciences, was a generous gift of
Elena Ivanova of the Pacific Institution of Bioorganic Chemistry,
Vladivostok, Russia. Activity against C. albicans was measured in sterilized 96-well plates (ICN
Biomedicals, Aurora, Ohio) according to the method of Mor et al.
(4). The concentrations of the synthetic peptide solutions
were determined by measuring the optical density at 275 nm due to
tyrosine, because the peptides did not include any other aromatic amino
acids and the acylation of the
-amino groups of the peptides did not
affect the absorbance. Different concentrations of peptides were added
to suspensions containing 106 spores/ml in Sabouraud
dextrose broth. The inhibition of growth was determined by measuring
the optical density at 492 nm after incubation for 24 h at
30°C with an MTP-22 microplate photometer (Corona, Ibaraki, Japan).
The effect of the peptides on cell viability was determined according
to the method of Langner et al. (2).
We have synthesized porcine NPY and its truncated analogs, in which 10 to 12 amino acids were eliminated and the N termini were replaced. The
MICs of all synthesized peptides are summarized in Table 1. Porcine NPY
had a MIC (10 to 12 µM) for C. albicans similar to that
reported for human NPY (30 µg/ml, 7 µM) (8). This result
was expected due to the fact that porcine NPY differs from human NPY
only in a single amino acid residue
position 17 has a leucine in
porcine NPY and a methionine in human NPY. All truncated and
N-terminally substituted analogs showed enhanced antimicrobial
activity. Especially the activities of
[Lys13]NPY(13-36),
[Asn12]NPY(12-36), and
[Lys11]NPY(11-36) were about 10-fold higher than
that of the intact NPY. A recent nuclear magnetic resonance study by
members of our group revealed that in such truncated analogs of NPY,
the
-helical region spans almost the entire length of the peptide
(7). These results suggest that only the
-helical region
of NPY is necessary for the antimicrobial activity.
The MICs tended to increase when acidic amino acids were located
at the N termini {[Asp13]NPY(13-36),
[Asp12]NPY(12-36),
[Glu12]NPY(12-36), and
[Glu11]NPY(11-36)}, suggesting that the
negative charges at the N terminus have a repressive effect on
the antimicrobial activity. This explanation is supported by the
results of the acylation of the
-amino groups in the analogs
except for [Lys12]NPY(12-36) (Table
2). Acetylation of
[Asn12]NPY(12-36),
[Thr12]NPY(12-36), and
[Asp12]NPY(12-36) increased the MIC, with a change
in the net charge at the N terminus from +1 to 0. Succinylation of
these analogs, in which the N-terminal charge was changed to
1, led
to more increased MICs.
In order to determine whether the activity of the peptides is
fungistatic or fungicidal, the viable cells were counted after incubation of the strain in the presence of NPY or
[Lys13]NPY(13-36), one of the most active
analogs, at concentrations which were 5- and 10-fold higher than their
MICs. The results shown in Table 3
indicate that the peptides were fungicidal for C. albicans.
The kinetic kill assay also indicated that the N-terminal truncation enhanced the antimicrobial activity of NPY.
Thus, we found that the fungicidal activity of porcine NPY for C. albicans was enhanced significantly by N-terminal truncation. The
enhancement of the activity in the truncated analogs can be explained,
at least partly, by the net charge. The truncated analogs have lost
charged amino acids in the N-terminal sequence (Lys4,
Asp6, Glu10, and Asp11), and the
net charge of the analogs was more positive than that of the intact
NPY. Such an increase in the net positive charge of the analogs is
expected to cause stronger electrostatic interactions with the target
membrane. The increase in negative charges by replacement of the N
termini with acidic amino acids or acylation of the
-amino groups is
considered to weaken this interaction. In the case of cecropin P1 from
pig intestine, a free amino terminus was identified to be essential for
its high antimicrobial activity (9). Because the truncated
analog of NPY with lysine at the N terminus retained high antimicrobial
activity after acylation, the
-amino group of the
N-terminal lysine seems to be able to substitute for the
-amino
group.
 |
ACKNOWLEDGMENTS |
We thank Kazuo Omi (Shionogi Research Laboratories,
Shionogi and Co., Ltd.) for helpful comments concerning the kinetic
kill assay in which dilution plating techniques were used.
Mayumi Shimizu was an Industrial Technology Researcher in the New
Energy and Industrial Technology Development Organization.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Osaka National
Research Institute, AIST, 1-8-31 Midorigaoka, Ikeda, Osaka 563-8577, Japan. Phone: 81-727-51-9521. Fax: 81-727-51-9628. E-mail:
yumoto{at}onri.go.jp.
 |
REFERENCES |
| 1.
|
Blondelle, S. E., and R. A. Houghten.
1992.
Design of model amphipathic peptides having potent antimicrobial activities.
Biochemistry
31:12688-12694[Medline].
|
| 2.
|
Langner, C. A.,
J. K. Lodge,
S. J. Travis,
J. E. Caldwell,
T. Lu,
Q. Li,
M. L. Bryant,
B. Devadas,
G. W. Gokel,
G. S. Kobayashi, and J. I. Gordon.
1992.
4-Oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I.
J. Biol. Chem.
267:17159-17169[Abstract/Free Full Text].
|
| 3.
|
Larhammar, D.,
C. Söderberg, and A. G. Blomqvist.
1993.
Evolution of the neuropeptide Y family of peptides, p. 1-30.
In
W. F. Colmers, and C. Wahlestedt (ed.), The biology of neuropeptide Y and related peptides. Humana Press, Totowa, N.J.
|
| 4.
|
Mor, A.,
K. Hani, and P. Nicolas.
1994.
The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms.
J. Biol. Chem.
269:31635-31641[Abstract/Free Full Text].
|
| 5.
|
Murase, S.,
N. Yumoto,
M. G. Petukhov, and S. Yoshikawa.
1996.
Acylation of the -amino group in neuropeptide Y(12-36) increases binding affinity for the Y2 receptor.
J. Biochem.
119:37-41[Abstract/Free Full Text].
|
| 6.
|
Schwartz, T. W.,
J. Fuhlendorff,
L. L. Kjems,
M. S. Kristensen,
M. Vervelde,
M. O'Hare,
J. L. Krstenansky, and B. Bjørnholm.
1990.
Signal epitopes in the three-dimensional structure of neuropeptide Y.
Ann. N.Y. Acad. Sci.
611:35-47[Medline].
|
| 7.
|
Uegaki, K.,
S. Murase,
N. Nemoto,
Y. Kobayashi,
S. Yoshikawa, and N. Yumoto.
1997.
Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y.
Biochem. Biophys. Res. Commun.
241:737-743[Medline].
|
| 8.
|
Vouldoukis, I.,
Y. Shai,
P. Nicolas, and A. Mor.
1996.
Broad spectrum antibiotic activity of skin-PYY.
FEBS Lett.
380:237-240[Medline].
|
| 9.
|
Vunnam, S.,
P. Juvvadi, and R. B. Merrifield.
1997.
Synthesis and antibacterial action of cecropin and proline-arginine-rich peptides from pig intestine.
J. Pept. Res.
49:59-66[Medline].
|
| 10.
|
Wahlestedt, C., and D. J. Reis.
1993.
Neuropeptide Y-related peptides and their receptors are the receptors potential therapeutic drug targets?
Annu. Rev. Pharmacol. Toxicol.
32:309-352.
|
Antimicrobial Agents and Chemotherapy, October 1998, p. 2745-2746, Vol. 42, No. 10
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rotem, S., Radzishevsky, I., Mor, A.
(2006). Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.. Antimicrob. Agents Chemother.
50: 2666-2672
[Abstract]
[Full Text]
-
Nordahl, E. A., Rydengard, V., Morgelin, M., Schmidtchen, A.
(2005). Domain 5 of High Molecular Weight Kininogen Is Antibacterial. J. Biol. Chem.
280: 34832-34839
[Abstract]
[Full Text]